Gargi Roy

Person

Boyds, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for promoting neuronal outgrowth
- Patent number 9,956,273
- Issue date May 1, 2018
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteoglycan degrading mutants for treatment of CNS
- Patent number 9,528,102
- Issue date Dec 27, 2016
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for promoting neuronal outgrowth
- Patent number 9,468,671
- Issue date Oct 18, 2016
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins for the treatment of CNS
- Patent number 8,906,363
- Issue date Dec 9, 2014
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for promoting neuronal outgrowth
- Patent number 8,785,606
- Issue date Jul 22, 2014
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for promoting neuronal outgrowth
- Patent number 8,183,350
- Issue date May 22, 2012
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteoglycan degrading mutants for the treatment of CNS
- Patent number 7,968,089
- Issue date Jun 28, 2011
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteoglycan degrading mutants for the treatment of CNS
- Patent number 7,429,375
- Issue date Sep 30, 2008
- Acorda Therapeutics, Inc.
- Elliott A. Gruskin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
FUSION PROTEINS FOR THE TREATMENT OF CNS
- Publication number 20180073007
- Publication date Mar 15, 2018
- ACORDA THERAPEUTICS, INC.
- Elliott A. GRUSKIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS
- Publication number 20170137799
- Publication date May 18, 2017
- ACORDA THERAPEUTICS, INC.
- Elliott A. GRUSKIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH
- Publication number 20160279210
- Publication date Sep 29, 2016
- ACORDA THERAPEUTICS, INC.
- Elliott A. Gruskin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUSION PROTEINS FOR THE TREATMENT OF CNS
- Publication number 20150299687
- Publication date Oct 22, 2015
- ACORDA THERAPEUTICS, INC.
- Elliott A. GRUSKIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH
- Publication number 20150023942
- Publication date Jan 22, 2015
- ACORDA THERAPEUTICS, INC.
- Elliott A. Gruskin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS
- Publication number 20140322192
- Publication date Oct 30, 2014
- ACORDA THERAPEUTICS, INC.
- Elliott A. GRUSKIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC PROTEIN
- Publication number 20130243765
- Publication date Sep 19, 2013
- ACORDA THERAPEUTICS, INC.
- Elliott A. Gruskin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH
- Publication number 20120207732
- Publication date Aug 16, 2012
- Elliott A. GRUSKIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS
- Publication number 20110250631
- Publication date Oct 13, 2011
- Elliott A. GRUSKIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Proteoglycan Degrading Mutants for the Treatment of CNS
- Publication number 20090041728
- Publication date Feb 12, 2009
- ACORDA THERAPEUTICS, INC.
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fusion proteins for the treatment of CNS
- Publication number 20090028829
- Publication date Jan 29, 2009
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Promoting Neuronal Outgrowth
- Publication number 20070274979
- Publication date Nov 29, 2007
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Proteoglycan degrading mutants for the treatment of CNS
- Publication number 20060233782
- Publication date Oct 19, 2006
- Elliott A. Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Chimeric protein
- Publication number 20060153827
- Publication date Jul 13, 2006
- Elliott A Gruskin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Compositions and methods for promoting neuronal outgrowth

Proteoglycan degrading mutants for treatment of CNS

Compositions and methods for promoting neuronal outgrowth

Fusion proteins for the treatment of CNS

Compositions and methods for promoting neuronal outgrowth

Compositions and methods for promoting neuronal outgrowth

Proteoglycan degrading mutants for the treatment of CNS

Proteoglycan degrading mutants for the treatment of CNS

Patents Applicationslast 30 patents

FUSION PROTEINS FOR THE TREATMENT OF CNS

PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS

COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH

FUSION PROTEINS FOR THE TREATMENT OF CNS

COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH

PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS

CHIMERIC PROTEIN

COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH

PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS

Proteoglycan Degrading Mutants for the Treatment of CNS

Fusion proteins for the treatment of CNS

Compositions and Methods for Promoting Neuronal Outgrowth

Proteoglycan degrading mutants for the treatment of CNS

Chimeric protein